Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Vogel

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Annals of the New York Academy of Sciences|January 1, 1987
Ascorbate-like factor from embryonic brain. Role in collagen formation, basement membrane deposition, and acetylcholine receptor aggregation by muscle cellsZ Vogel, M P Daniels, T Chen, et al.
European Journal of Pharmacology|August 28, 1998
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activityS Ben-Shabat, E Fride, T Sheskin, et al.
The Journal of Biological Chemistry|May 25, 2001
D2/D3 dopamine receptor heterodimers exhibit unique functional propertiesM Scarselli, F Novi, E Schallmach, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Buprenorphine differentially alters opioid receptor adaptation in rat brain regionsM M Belcheva, M T Ho, E G Ignatova, et al.
Cell Death & Disease|December 7, 2013
Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell deathN Rimmerman, D Ben-Hail, Z Porat, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 10, 2015
TCAIM decreases T cell priming capacity of dendritic cells by inhibiting TLR-induced Ca2+ influx and IL-2 productionSimone Z Vogel, Stephan Schlickeiser, Karsten Jürchott, et al.
Brain Research. Molecular Brain Research|August 1, 1997
Ras-GRF, the activator of Ras, is expressed preferentially in mature neurons of the central nervous systemR Zippel, N Gnesutta, N Matus-Leibovitch, et al.
Annals of the New York Academy of Sciences|January 17, 1996
M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical updateA Fisher, E Heldman, D Gurwitz, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Annals of the New York Academy of Sciences|January 1, 1987
Ascorbate-like factor from embryonic brain. Role in collagen formation, basement membrane deposition, and acetylcholine receptor aggregation by muscle cellsZ Vogel, M P Daniels, T Chen, et al.
European Journal of Pharmacology|August 28, 1998
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activityS Ben-Shabat, E Fride, T Sheskin, et al.
The Journal of Biological Chemistry|May 25, 2001
D2/D3 dopamine receptor heterodimers exhibit unique functional propertiesM Scarselli, F Novi, E Schallmach, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Buprenorphine differentially alters opioid receptor adaptation in rat brain regionsM M Belcheva, M T Ho, E G Ignatova, et al.
Cell Death & Disease|December 7, 2013
Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell deathN Rimmerman, D Ben-Hail, Z Porat, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 10, 2015
TCAIM decreases T cell priming capacity of dendritic cells by inhibiting TLR-induced Ca2+ influx and IL-2 productionSimone Z Vogel, Stephan Schlickeiser, Karsten Jürchott, et al.
Brain Research. Molecular Brain Research|August 1, 1997
Ras-GRF, the activator of Ras, is expressed preferentially in mature neurons of the central nervous systemR Zippel, N Gnesutta, N Matus-Leibovitch, et al.
Annals of the New York Academy of Sciences|January 17, 1996
M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical updateA Fisher, E Heldman, D Gurwitz, et al.
Pageof 13